Abstract P233: Sodium Glucose Transporter Type-2 (SGLT-2) Inhibitor, Empagliflozin, Improves Cardiovascular Outcomes in Female Diabetic db/db Mice Independent of Blood Pressure Reduction

James R. Sowers; Annayya R. Aroor; Guanghong Jia; Ravi Nistala; Mona Garro; Gerald A. Meininger; Luis A. Martinez‐Lemus; Eric Mayoux; Adam Whaley‐Connell; Vincent G. DeMarco

doi:10.1161/hyp.66.suppl_1.p233

Abstract P233: Sodium Glucose Transporter Type-2 (SGLT-2) Inhibitor, Empagliflozin, Improves Cardiovascular Outcomes in Female Diabetic db/db Mice Independent of Blood Pressure Reduction

Identifier:nobleid.org/w1/20260515/CBFFECF7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CBFFECF7.svg?ark=w1%2F20260515%2FCBFFECF7)](https://nobleid.org/work/w1/20260515/CBFFECF7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Luis A. Martinez‐Lemus

Eric Mayoux

Adam Whaley‐Connell

Vincent G. DeMarco

Claim authorship of this work

Abstract P233: Sodium Glucose Transporter Type-2 (SGLT-2) Inhibitor, Empagliflozin, Improves Cardiovascular Outcomes in Female Diabetic db/db Mice Independent of Blood Pressure Reduction

Identifier:nobleid.org/w1/20260515/CBFFECF7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CBFFECF7.svg?ark=w1%2F20260515%2FCBFFECF7)](https://nobleid.org/work/w1/20260515/CBFFECF7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Luis A. Martinez‐Lemus

Eric Mayoux

Adam Whaley‐Connell

Vincent G. DeMarco

Claim authorship of this work